Eric S. Fain's most recent trade in Orchestra BioMed Holdings Inc was a trade of 5,760 Common Stock, par value $0.0001 per share done at an average price of $2.6 . Disclosure was reported to the exchange on Aug. 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Purchase of securities on an exchange or from another person at price $ 2.61 per share. | 25 Aug 2025 | 5,760 | 71,709 | - | 2.6 | 15,034 | Common Stock, par value $0.0001 per share |
| Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2025 | 7,500 | 7,500 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") | |
| Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2025 | 7,500 | 58,449 | - | 0 | Common Stock | |
| Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Sale of securities on an exchange or to another person at price $ 3.05 per share. | 26 Jun 2025 | 2,683 | 50,949 | - | 3.0 | 8,183 | Common Stock, par value $0.0001 per share ("Common Stock") |
| Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 36,797 | 36,797 | - | - | Stock Option (Right to Buy) | |
| Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 12,422 | 53,632 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") | |
| Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Sale of securities on an exchange or to another person at price $ 5.64 per share. | 06 Sep 2024 | 2,000 | 44,810 | - | 5.6 | 11,280 | Common Stock, par value $0.0001 per share ("Common Stock") |
| Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Sale of securities on an exchange or to another person at price $ 5.34 per share. | 06 Sep 2024 | 1,800 | 41,210 | - | 5.3 | 9,612 | Common Stock |
| Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Sale of securities on an exchange or to another person at price $ 5.43 per share. | 06 Sep 2024 | 1,800 | 43,010 | - | 5.4 | 9,774 | Common Stock |
| Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 17,068 | 17,068 | - | - | Stock Option (Right to Buy) | |
| Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 5,376 | 46,810 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") | |
| Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2023 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2023 | 11,667 | 41,434 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") | |
| Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2023 | 2,906 | 0 | - | - | Warrant (Right to Buy) | |
| Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 10 May 2023 | 2,906 | 29,767 | - | 1.1 | 3,138 | Common Stock, par value $0.0001 per share ("Common Stock") |
| Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 23,250 | 23,250 | - | - | Nonstatutory Stock Option (Right to Buy) |